Literature DB >> 16009516

Calorimetric determination of amorphous content in lactose: a note on the preparation of calibration curves.

Rita Ramos1, Simon Gaisford, Graham Buckton.   

Abstract

Calorimetric methods (isothermal or solution calorimetry) offer the ability to detect amorphous contents to 0.5% (w/w) or better in processed pharmaceuticals and calorimetric data are becoming more widely accepted in regulatory submissions. However, both methods require the construction of calibration curves, prepared using quantitative physical mixtures of entirely amorphous and entirely crystalline material. If the sample under investigation exists in two or more isomers or polymorphs, and the enthalpy of solution (solution calorimetry) or the enthalpy of crystallisation (isothermal calorimetry) are different for the isomers or polymorphs, then it must be ensured that the batch of material used to prepare the calibration samples has the same isomeric or polymorphic composition as the (processed) material to be tested. Here, we demonstrate the problems that may arise using lactose as a pharmaceutically important model substance. Calibration curves were prepared from solution calorimetry and isothermal gas perfusion calorimetry data using two batches of lactose (one predominantly anhydrous alpha-lactose and one predominantly beta-lactose). The calibration curves are shown to be significantly different for the two batches, and it is shown that quantification of the amorphous content of a processed sample of unknown isomeric composition is impossible, unless the calibration curve is prepared from the same batch of material as the processed sample. In addition, some of the other problems inherent in using isothermal gas perfusion calorimetry for amorphous content determination, such as wetting issues and the preparation of calibration standards that mimic processes samples, are discussed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16009516     DOI: 10.1016/j.ijpharm.2005.04.022

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  3 in total

1.  Investigation into the influence of primary crystallization conditions on the mechanical properties and secondary processing behaviour of fluticasone propionate for carrier based dry powder inhaler formulations.

Authors:  Harshal A Kubavat; Jagdeep Shur; Graham Ruecroft; David Hipkiss; Robert Price
Journal:  Pharm Res       Date:  2011-12-09       Impact factor: 4.200

2.  The measurement of the β/α anomer composition within amorphous lactose prepared by spray and freeze drying using a simple (1)H-NMR method.

Authors:  Rim Jawad; Carole Elleman; Louic Vermeer; Alex F Drake; Brendon Woodhead; Gary P Martin; Paul G Royall
Journal:  Pharm Res       Date:  2011-09-08       Impact factor: 4.200

3.  Chemico-calorimetric analysis of amorphous granules manufactured via continuous granulation process.

Authors:  Mridul Majumder; Saeid Rajabnezhad; Ali Nokhodchi; Mohammed Maniruzzaman
Journal:  Drug Deliv Transl Res       Date:  2018-12       Impact factor: 4.617

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.